Cargando…
Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid
Pneumolysin is a highly conserved, cholesterol-dependent cytolysin that is an important Streptococcus pneumoniae virulence factor and an attractive target for vaccine development. To attenuate pneumolysin toxicity, a genetic toxoid was constructed with two amino acid changes, G293S and L460D, termed...
Autores principales: | Thanawastien, Ann, Joyce, Kelsey E., Cartee, Robert T., Haines, Laurel A., Pelton, Stephen I., Tweten, Rodney K., Killeen, Kevin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237519/ https://www.ncbi.nlm.nih.gov/pubmed/32532546 http://dx.doi.org/10.1016/j.vaccine.2020.04.064 |
Ejemplares similares
-
The Impact of Pneumolysin on the Macrophage Response to Streptococcus pneumoniae is Strain-Dependent
por: Harvey, Richard M., et al.
Publicado: (2014) -
A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever
por: Cartee, Robert T., et al.
Publicado: (2020) -
Mouse, but Not Human, ApoB-100 Lipoprotein Cholesterol Is a Potent Innate Inhibitor of Streptococcus pneumoniae Pneumolysin
por: Wade, Kristin R., et al.
Publicado: (2014) -
Crystal structure of Streptococcus pneumoniae pneumolysin provides key insights into early steps of pore formation
por: Lawrence, Sara L., et al.
Publicado: (2015) -
Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen
por: Hermand, Philippe, et al.
Publicado: (2016)